ScholarIQanswers from OpenAlex

A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis

PaperCitations, authors & open-access status

A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis have?

ScholarIQcitation count

A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis has 214 citations in the OpenAlex counts ScholarIQ stores.

When was A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis published?

ScholarIQyear

A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis has 2015 year in the ScholarIQ index.

What is the open-access status of A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis?

ScholarIQoa status

A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis has hybrid oa status in the ScholarIQ index.

What is the DOI of A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis?

ScholarIQdoi

The DOI for A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis is on the source record.

What is the PMID of A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis?

ScholarIQpmid

The PMID for A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis is on the source record.

What is the OpenAlex record for A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis?

ScholarIQopenalex

The OpenAlex for A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial